Expression and its significance of TSG101 in lung cancer tissue and lung cancer cell lines

Chinese Journal of Lung Cancer

Volumn 11, Issue 2, 2008, Pages 172-177

  Cai, Cunwei ^a   Zhang, Daorong ^c   Lu, Ping ^b   Gao, Yanhua ^c   Chang, Jiahui ^c  

^a CHINA MEDICAL UNIVERSITY   (China)

^b QIQIHAR MEDICAL UNIVERSITY   (China)

^c NONE

Author keywords

Alternative splicing; Lung neoplasms; TSG101 protein

Indexed keywords

TUMOR SUSCEPTIBILITY GENE 101 PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER TISSUE; EMBRYO; GENETIC TRANSCRIPTION; IMMUNOHISTOCHEMISTRY; LUNG CANCER; LUNG SMALL CELL CANCER; METHODOLOGY; MOUSE; NONHUMAN; PROGNOSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SPLICING; WESTERN BLOTTING; WILD TYPE;

EID: 43649107399     PISSN: 10093419     EISSN: 19996187     Source Type: Journal    
DOI: 10.3779/j.issn.1009-3419.2008.02.012     Document Type: Article

References (12)

1. Li L, Cohen SN. Tsg101: a novel tumor susceptibility gene isolated by controlled homozygous functional knockout of allelic loci in mammalian cells. Cell, 1996, 85(3): 319-329.
2. Waqner KU, Dierisseau P, Rucker EB 3rd, et al. Genomic architecture and transcriptionalactivation of the mouse and human tumor susceptibility gene TSG101: common types of shorter transcripts are true alternative splice variants. Oncogene, 1998, 17(21): 2761-2770.
3. Lu P, Zhang DR, Gao YH, et al. Expression and significance of TSG101, P21 and P300/CBP in squamous cell carcinom and adenoeacinoma of the lung. Chin J Lung Cancer, 2007, 10 (3): 196-202.
4. Lee MP, Feinberg AP. Aberrant Splicing but not Mutations of TSG101 in Human Breast Cancer. Cancer Res, 1997, 57(15): 3131-3134.
5. Li L, Liao J, Ruland J, et al. A TSG101/MDM2 regulatory loop modulates MDM2 degradation and MDM2/p53 feed back control. Proc Natl Acad Sci USA, 2001, 98(4): 1619-1624.
6. Ferrer M, Lopez-Borges S, Lazo PA. Expression of a new isoform of the tumor susceptibility TSG101 protein lacking a leucine zipper domain in Burkitt lymphoma celllines. Oncogene, 1999, 18(13): 2253-2259.
7. Ferrer M, Hernández S, Campo E, et al. Loss of the TSG101 leucine zipper domain in aggressive non-Hodgkins lymphoma. Leukemia, 2000, 14(11): 2014-2016.
8. Lupas A. Coiled coils: new structures and new functions. Trends Biochem Sci, 1996, 21(10): 375-378.
9. Oh Y, Protor M, Fan YH, et al. TSG101 is not mutated in lung cancer but a shortened transcrpt is frequently in samal cell lung cancer. Oncogene, 1998, 17(9): 1141-1148.
10. Bennett NA, Patillo RA, Lin RS, et al. TSG101expression in gynaecological tumors;relationship to cyclinD1, cyclinE, p53 and p16 proteins. Cell Mol Biol, 2001, 47(7): 1187-1193.
11. R.Klaes, M.Kloor, F.Wileke. et al. Significant Increase of a Specific Variant TSG101 Transcript during the Progression of Cervical Neoplasia. Eur J Cancer, 1999, 35(5): 733-737.
12. Kenneth H. Moberg, Suzanne Schelble, et al. Mutations in erupted, the Drosophila ortholog of mammalian tumor susceptibility gene 101, elicit non-cell-autonomous overgrowth. Dev Cell, 2005, 9(5): 699-710.